26
Mar

Gastro drug developer Synergy Pharmaceuticals is considering putting itself up for sale, Bloomberg reports, perhaps emboldened by the high price secured by competitor Salix Pharmaceuticals.

…read more

Source: After Salix’s $10B deal, is Synergy Pharma on the block?

    

0 No comments